Position in OCGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$49,841
+$36,462 QoQ
Shares Held
32,576
+71.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 147 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $118,479,041 across 122 Biotechnology names. OCGN ranks #107 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,980 | $22,839,645 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,063 | $11,263,003 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
30,242 | $9,103,749 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
40,460 | $7,577,348 | |
| 5 | INSM |
INSMED Inc
|
48,273 | $5,146,867 | |
| 6 | INCY |
Incyte Corp
|
29,027 | $3,290,500 | |
| 7 | RPRX |
Royalty Pharma plc
|
55,752 | $3,126,014 | |
| 8 | MRNA |
Moderna, Inc.
|
39,368 | $2,756,941 |
All Filings in OCGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,841 | 32,576 | Shares | Sole | 2026-08-10 | |
| 2025-03-31 | $13,379 | 18,951 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $14,861 | 18,462 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $16,616 | 16,751 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $24,584 | 15,861 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $10,543 | 12,360 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $16,068 | 12,360 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $21,320 | 11,978 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $26,164 | 11,526 | Shares | Sole | 2022-08-02 | |
| 2021-06-30 | $81,191 | 10,111 | Shares | Sole | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||